Atrial Fibrillation Trial, Recruiting NCT04844801 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT04844801
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with or are suspected to have a serious infection, and have been started on antibiotics
  • You need medication to keep your blood pressure stable (specifically norepinephrine or epinephrine) and have been on it for at least 1 hour
  • You have a fast, irregular heart rhythm (coming from the upper chambers of the heart) with a heart rate of 110 beats per minute or more, lasting at least 5 minutes
  • You (or your next of kin, or under emergency consent procedures) have given written agreement to take part
  • You are covered by a social security/health insurance system (this applies mainly to patients in France — confirm with trial site)

Who may not be able to join:

  • Your condition is very severe and requires very high doses of blood pressure medication (above a certain threshold — confirm with trial site)
  • You have had heart surgery or a heart transplant in the past month
  • You have a mechanical heart valve in the aortic or mitral position, or have a significantly narrowed mitral valve
  • You have a structural heart defect from birth, other than certain minor ones (such as a bicuspid aortic valve, a small hole between the upper heart chambers, or a patent foramen ovale)
  • You had a pre-existing fast, irregular heart rhythm condition before this illness that required long-term medication to manage it, or you have had this type of irregular rhythm permanently
  • Your irregular heart rhythm started more than 48 hours ago (or more than 24 hours ago if you are already on blood pressure medication) — though in some cases, extra tests may allow participation (confirm with trial site)
  • You have received an electrical shock to reset your heart rhythm, or been given certain heart rhythm or rate-controlling medications, in the 6 hours before joining the trial
  • You have a known reason why you cannot take the medication amiodarone, such as a past bad reaction to it, certain thyroid problems, certain lung conditions, certain abnormal heart rhythm readings on an ECG, a pacemaker-related issue, severe liver problems, or allergy to iodine or amiodarone
  • Your potassium level in your blood is too low (below 3 mmol/L)
  • You are pregnant or breastfeeding
  • You are not expected to survive your current illness, you are detained or under court-ordered psychiatric care
  • You are already taking part in another clinical trial related to serious infection or heart rhythm problems

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Vincent LABBE, MD, Assistance Publique - Hôpitaux de Paris

Phone: 01 56 01 69 37

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 November 2021
Est. completion
1 February 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

all-cause mortality (a hierarchical criterion); the duration of septic shock according to the Finkelstein-Schoenfeld method (a hierarchical criterion).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov